Skip to content
healthcare.dev

Fycompa

NDC 69616-274, perampanel, tablet, from Catalyst Pharmaceuticals, Inc..

Product NDC
69616-274
Status
Listed
Labeler
Catalyst Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA202834
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69616-274 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PERAMPANEL4 mg/1

Pharmacologic classes

AMPA Receptor Antagonists [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]; UGT1A9 Inhibitors [MoA]; UGT2B7 Inhibitors [MoA]

Package NDCNDC-11Package
69616-274-146961602741414 TABLET in 1 PACKAGE (69616-274-14)
69616-274-306961602743030 TABLET in 1 BOTTLE (69616-274-30)
69616-274-906961602749090 TABLET in 1 BOTTLE (69616-274-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ec812ea3-de3a-4271-957c-db8f692d1ae3
  • NADAC price for package 69616027430

    GET /v1/drugs/nadac/69616027430

Use it

Look up 69616-274 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69616-274 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69616-274. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.